- Home
- BLFS vs INMD Comparison
BLFS vs INMD Comparison
Compare BLFS & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLFS | INMD |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 923.5M | 842.0M |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BLFS | INMD |
|---|---|---|
| Price | $21.91 | $13.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 5 |
| Target Price | ★ $32.00 | $17.33 |
| AVG Volume (30 Days) | 326.0K | ★ 653.9K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.27 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $96,214,000.00 | N/A |
| Revenue This Year | $19.73 | $1.74 |
| Revenue Next Year | $17.82 | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | ★ 16.97 | N/A |
| 52 Week Low | $17.86 | $12.72 |
| 52 Week High | $29.57 | $16.74 |
Technical Indicators
Market Signals| Indicator | BLFS | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 56.20 | 47.19 |
| Support Level | $21.35 | $13.32 |
| Resistance Level | $26.14 | $14.70 |
| Average True Range (ATR) | 1.03 | 0.30 |
| MACD | 0.10 | -0.07 |
| Stochastic Oscillator | 68.35 | 47.95 |
Price Performance
Historical ComparisonAbout BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.